Despite his success as an actor on the national stage,

New Post Public Reply Private Reply Replies (0) Message Board
dw
118

Despite his success as an actor on the national stage, John Wilkes Booth will forever be known as the man who assassinated President Abraham Lincoln. Booth, a native of Maryland, was a fierce Confederate sympathizer during the Civil War. Before the fateful night at Ford’s Theatre, he had conspired to kidnap Lincoln and hide him until all Confederate prisoners were released. On April 14, 1865, Booth entered the theater’s balcony, shot Lincoln at close range and immediately fled the scene. After a 12-day manhunt, Booth was tracked down and killed by Union soldiers.

The celebrated actor Junius Brutus Booth immigrated to the United States from England in the early 1820s and settled his family in Harford County, Maryland, where the ninth of his 10 children, John Wilkes, was born on May 10, 1838. In 1846, it was revealed that Junius Booth had neglected to divorce his first wife before eloping with his second, Mary Ann, 25 years before. The scandal made an impression on young John Wilkes, who was fiercely proud of his illustrious family name.

After his father’s death in 1852, Booth left his studies at the prestigious military school St. Timothy’s Hall. In 1855, he followed his older brothers, Junius Jr. and Edwin, into the acting profession, making his debut in Shakespeare’s Richard III at the Charles Street Theatre in Baltimore. Booth worked for a year at a Philadelphia theater before moving to the Marshall Theatre in Richmond, Virginia, where he became known for his dark good looks, his intensely physical, almost acrobatic, performances and his popularity with women.

In October 1859, Booth–who, like many Marylanders, supported slavery–was shocked and galvanized by the abolitionist John Brown’s bloody raid on Harper’s Ferry, Virginia. Booth briefly enlisted in the Richmond militia and witnessed Brown’s hanging in December. That summer, he signed on as the leading man in a touring theater company. Booth was about to take on the part of Hamlet in October 1860 when he accidentally shot himself in the thigh with a co-star’s pistol. Abraham Lincoln was elected president one month later, and Booth watched the South move toward secession while recuperating in Philadelphia.

Shortly after the outbreak of the Civil War, Lincoln declared martial law in Maryland as part of an effort to keep the state from seceding. Angry and frustrated, Booth nonetheless promised his mother he would never enlist in the Confederate Army. He continued his acting career, drawing crowds and impressing critics from St. Louis to Boston. In November 1863, he performed in The Marble Heart at Washington’s Ford’s Theatre. In the audience were President and Mrs. Lincoln. It was the only time Lincoln would see Booth perform.

In late May 1864, Booth invested in an oil company in western Pennsylvania. After seeing no immediate profit, he backed out of the operation, losing most of his savings. By that time, he had already begun working on his conspiracy to kidnap Lincoln. He performed less and less frequently, and by late 1864 had gone into debt. Booth attended Lincoln’s second inaugural in early March with his secret fiancée Lucy Hale, the daughter of an abolitionist New Hampshire senator. In what would be his last performance, Booth appeared in front of a full house at Ford’s in The Apostate on March 28, 1865.

Less than a week later, Confederate forces evacuated Richmond, and within two weeks, General Robert E. Lee surrendered his troops. As Washington exploded in celebration, Booth attended another Lincoln speech on April 11, reacting strongly to Lincoln’s suggestion that he would pursue voting rights for blacks. Booth angrily told his co-conspirator, Davy Herold: “Now, by God, I’ll put him through.” Three days later, at Ford’s Theatre, John Wilkes Booth made good on his word.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 190

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 230

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 242

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 59

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 80

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 299

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 242

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 104

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Macao's 25-Year Journey: Celebrating Growth and Prosperity

Updated Category News Views 161

Macao's Remarkable Development Over 25 Years In a vibrant celebration of progress, Macao recently marked the significant milestone of its 25th anniversary since its return to the motherland. A special publication by an English-language newspaper highlighted various achievements that the region has made during this transformative period. Economic Growth and Transformation...

Continue Reading
Opportunity to Address Losses: Join Tempus AI Class Action

Updated Category News Views 128

Investors Encouraged to Participate in Tempus AI Class Action The law firm Robbins Geller Rudman & Dowd LLP is actively reaching out to investors of Tempus AI, Inc. (NASDAQ: TEM) who have experienced notable financial losses. They have announced an opportunity for eligible investors to take the lead in an associated class action lawsuit. This potential action stems from...

Continue Reading
Muncy Columbia Financial Corporation's Strong Q4 2024 Earnings

Updated Category News Views 99

Muncy Columbia Financial Corporation's Financial Outlook Muncy Columbia Financial Corporation (“Corporation”) (OTCQX: CCFN), after releasing its unaudited consolidated financial statements for the fourth quarter of 2024, has demonstrated significant improvement over the previous year. Fourth Quarter 2024 Financial Highlights For the quarter ending December 31, 2024,...

Continue Reading
Caris Life Sciences Expands Cancer Research Alliance

Updated Category News Views 119

Caris Life Sciences Expands Cancer Research Alliance Caris Life Sciences® (NASDAQ: CAI), a forefront player in precision medicine and next-generation AI TechBio, is excited to share the arrival of Providence Swedish Cancer Institute into the esteemed Caris Precision Oncology Alliance (Caris POA). This addition enhances their collective mission to revolutionize cancer...

Continue Reading
Zumiez Inc. Gears Up for First Quarter 2025 Financial Report

Updated Category News Views 263

Upcoming Financial Report for Zumiez Inc. Zumiez Inc. (NASDAQ: ZUMZ) has recently made an exciting announcement regarding its financial performance. The company is set to release its first quarter results for fiscal 2025 on June 5, after the stock market closes. This pivotal moment is eagerly anticipated by investors and stakeholders alike, as it will provide valuable...

Continue Reading